Clozapine/lithiumNeuroleptic malignant syndrome following drug-drug interaction: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1975卷 / 1期

关键词：

D O I：

10.1007/s40278-023-46483-1

中图分类号：

学科分类号：

摘要：

引用

页码：128 / 128

共 50 条

[31] Clozapine/tozinameranVarious toxicities following drug interaction: case report
Reactions Weekly, 2022, 1897 (1) : 126 - 126
[32] Multiple drugsSerotonin syndrome following drug-drug interaction
Reactions Weekly, 2024, 2007 (1) : 258 - 258
[33] Pharmacokinetic drug-drug interaction between clozapine and brexpiprazole: A case series
Cereda, G.
Lazzaretti, M.
Colli, C.
Fontana, E.
Enrico, P.
Pigoni, A.
Baldelli, S.
Cattaneo, D.
Clementi, E.
Brambilla, P.
SCHIZOPHRENIA RESEARCH, 2023, 261 : 15 - 17
[34] Brexpiprazole/Clozapine interactionRelapse of schizophrenia, decreased blood drug levels of clozapine following pharmacokinetic drug-drug interaction
Reactions Weekly, 2024, 2010 (1) : 90 - 90
[35] Droperidol/olanzapine interactionExtrapyramidal symptoms following drug-drug interaction: case report
Reactions Weekly, 2022, 1908 (1) : 230 - 230
[36] Multiple drugsPancytopenia following misuse and drug-drug interaction and gout: case report
Reactions Weekly, 2021, 1859 (1) : 250 - 250
[37] Multiple drugsDeath following overdose, poisoning and drug-drug interaction: case report
Reactions Weekly, 2023, 1967 (1) : 251 - 251
[38] Insulin/ipatasertibHyperglycaemia, and inuslin resistance following drug-drug interaction: case report
Reactions Weekly, 2022, 1914 (1) : 262 - 262
[39] Multiple drugsEuglycaemic diabetic ketoacidosis following drug-drug interaction: case report
Reactions Weekly, 2021, 1852 (1) : 294 - 294
[40] Bosutinib/DofetilideQTc prolongation following drug-drug pharmacokinetic interaction: case report
Reactions Weekly, 2025, 2052 (1) : 98 - 98

← 1 2 3 4 5 →